-

08:12:09 AM

LIVE Real Time IQV Stock Market News

IQV - IQVIA Holdings Inc

04/22/21 7:00 AM

NYSE : IQV

IQVIA Reports First-Quarter Results; Raises Full-Year 2021 Guidance

IQVIA Holdings Inc. ("IQVIA") (NYSE:IQV), a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry, today reported financial results for the quarter ended March 31, 2021.First-Quarter 2021 Operating ResultsRevenue for the

RHEA-AI

neutral

04/06/21 1:00 PM

NYSE : IQV

IQVIA to Announce First-Quarter 2021 Results on April 22, 2021

IQVIA Holdings Inc. ("IQVIA") (NYSE:IQV) will announce its first-quarter 2021 financial results before the market opens on Thursday, April 22, 2021. The IQVIA management team will also host a conference call and webcast at 9:00 a.m. Eastern Time on that date. The earnings release and accompanying

RHEA-AI

neutral

04/06/21 7:30 AM

Nasdaq, NYSE : MBRX, IQV

Moleculin Engages IQVIA to Manage Potential COVID-19 Clinical Trial

Moleculin Biotech, Inc., (Nasdaq: MBRX) (Moleculin or the Company), a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting highly resistant tumors and viruses, today announced the engagement of IQVIA Biotech, a contract

RHEA-AI

neutral

04/01/21 7:03 AM

NYSE : DGX, IQV

Quest Diagnostics Sells Ownership Interest in Q? Solutions to IQVIA

Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced the sale of its minority share in Q 2 Solutions to IQVIA (NYSE: IQV), a leading global provider of advanced

RHEA-AI

neutral

04/01/21 7:00 AM

NYSE : IQV

IQVIA Acquires Remaining Interest in Q2 Solutions from Quest Diagnostics; Raises Full Year 2021 Adjusted Diluted EPS Guidance

IQVIA Holdings Inc. ("IQVIA") (NYSE:IQV), a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry, today announced the acquisition of the 40 percent minority share of Q 2 Solutions from Quest Diagnostics (NYSE: DGX), the

RHEA-AI

neutral

03/09/21 8:00 AM

NYSE : IQV

IQVIA Virtual Trial Solutions Used in More than 60 Trials

IQVIA (TM) (NYSE:IQV) announced today that more than 60 trials spanning over 40 countries utilize its innovative decentralized clinical trial solutions as part of their respective registration trials. Many of these trials, launched in 2020 as virtual and patient-centric solutions, are providing

RHEA-AI

neutral

03/08/21 8:00 AM

NYSE : IQV

IQVIA Collaborating with Janssen Research & Development on Their Investigational COVID-19 Vaccine Trials

IQVIA(TM) (NYSE: IQV) announces that since September 2020 it has been collaborating with Janssen Research & Development, LLC, one of the Janssen Pharmaceutical Companies of Johnson & Johnson, on the Phase 3 COVID-19 vaccine clinical trials.The studies leverage IQVIA's suite of decentralized trial

RHEA-AI

neutral

03/02/21 4:15 PM

NYSE : IQV

IQVIA to Participate in the Barclays Global Healthcare Conference on March 09, 2021

IQVIA Holdings Inc. ("IQVIA") (NYSE:IQV), announced today that Ron Bruehlman, executive vice president and chief financial officer, will participate in a virtual fireside chat at the Barclays Global Healthcare Conference on Tuesday, March 09, 2021 at 3:00 p.m. EST.A live audio webcast of the

RHEA-AI

neutral

02/17/21 4:27 PM

NYSE : IQV

IQVIA Announces Pricing of Offering of Senior Notes

IQVIA Holdings Inc. ("IQVIA") (NYSE:IQV) today announced that its wholly owned subsidiary, IQVIA Inc. (the "Issuer"), priced an offering of EUR1,450,000,000 in aggregate principal amount of senior notes, consisting of EUR550,000,000 in aggregate principal amount of senior notes due 2026 (the "2026

RHEA-AI

neutral

02/16/21 3:26 AM

NYSE : IQV

IQVIA Announces Offering of Senior Notes

IQVIA Holdings Inc. ("IQVIA") (NYSE:IQV) today announced that its wholly owned subsidiary, IQVIA Inc. (the "Issuer"), intends to raise EUR1,450,000,000 in gross proceeds (equivalent to approximately $1,761,000,000) through an offering of senior notes due 2026 and senior notes due 2029 (collectively,

RHEA-AI

neutral